Microvillus inclusion disease
my-kroh-VIL-us in-KLOO-zhun dih-ZEEZ
Also known as: congenital microvillus atrophy, familial enteropathy
At a Glance
What is Microvillus inclusion disease?
Microvillus inclusion disease is a rare genetic disorder that primarily affects the intestines. It is caused by mutations in the MYO5B gene, leading to defective protein function. This condition results in severe, chronic diarrhea starting in the first days of life. The disease affects the gastrointestinal system, causing malabsorption and failure to thrive. Early symptoms include watery diarrhea and dehydration, while later symptoms may involve malnutrition and growth delays. Early diagnosis is critical to manage symptoms and prevent life-threatening complications. The condition places a significant emotional and financial burden on families due to the need for lifelong medical care. Prognosis varies, but many affected individuals require parenteral nutrition to survive. Daily life for those affected often involves frequent hospital visits and careful dietary management. The disease does not typically affect cognitive development, but physical growth may be impaired. Treatment focuses on symptom management, as there is currently no cure. Advances in genetic research offer hope for future therapeutic interventions.
Medical Definition
Microvillus inclusion disease is characterized by the presence of intracellular inclusions within enterocytes, leading to a loss of microvilli on the apical surface. Histologically, it is identified by periodic acid-Schiff-positive inclusions in the intestinal epithelial cells. The disease is classified under congenital diarrheal disorders and is caused by mutations in the MYO5B gene. It is a rare condition with a higher prevalence in populations with high rates of consanguinity. The disease course is chronic and typically manifests shortly after birth. Management involves supportive care, primarily through parenteral nutrition, to address severe malabsorption and dehydration.
Microvillus inclusion disease Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Chronic diarrhea in microvillus inclusion disease manifests as frequent, watery stools that can lead to severe dehydration. This symptom is caused by the inability of the intestinal cells to properly absorb nutrients and fluids due to defective microvilli. Over time, chronic diarrhea can lead to malnutrition and growth delays if not managed effectively. Daily life is significantly impacted as patients require constant hydration and nutritional support, often through parenteral nutrition.
Failure to thrive is characterized by inadequate weight gain and growth in infants and children with microvillus inclusion disease. This occurs because the intestinal malabsorption prevents essential nutrients from being absorbed into the body. As the condition progresses, growth parameters continue to fall below expected levels for age and sex. Management involves intensive nutritional support and monitoring to ensure adequate caloric intake and growth.
Severe dehydration results from the excessive loss of fluids through chronic diarrhea. The underlying mechanism is the impaired absorption of water in the intestines due to dysfunctional microvilli. Without proper intervention, dehydration can rapidly worsen, leading to electrolyte imbalances and potentially life-threatening complications. Patients require prompt rehydration therapy and ongoing fluid management to maintain hydration levels.
Common
Electrolyte imbalances occur due to the loss of electrolytes in the stool, a consequence of chronic diarrhea. The disruption in electrolyte levels is a direct result of the impaired absorptive capacity of the intestinal cells. Over time, these imbalances can lead to symptoms such as muscle weakness, fatigue, and cardiac arrhythmias. Regular monitoring and supplementation of electrolytes are necessary to prevent complications.
Abdominal distension in microvillus inclusion disease is often due to the accumulation of unabsorbed fluids and gases in the intestines. This symptom arises from the malabsorption and fermentation of nutrients in the gut. Over time, distension can cause discomfort and pain, impacting the patient's quality of life. Management includes dietary modifications and medications to reduce gas production and improve comfort.
Vomiting is a common symptom that may occur intermittently in individuals with microvillus inclusion disease. It is often triggered by the body's response to intestinal malabsorption and the presence of unabsorbed nutrients. Persistent vomiting can exacerbate dehydration and nutritional deficiencies over time. Antiemetic medications and careful dietary management can help control this symptom.
Less Common
Hypoglycemia, or low blood sugar, can occur due to inadequate nutrient absorption and the body's increased metabolic demands. The condition arises when glucose levels fall below normal, often due to insufficient caloric intake. If not addressed, hypoglycemia can lead to symptoms such as dizziness, confusion, and even seizures. Regular monitoring of blood glucose levels and timely nutritional support are crucial to prevent episodes.
Metabolic acidosis in microvillus inclusion disease results from the accumulation of acidic compounds in the blood due to malabsorption. The condition is characterized by a decrease in blood pH, leading to symptoms such as rapid breathing and fatigue. Over time, untreated metabolic acidosis can impair organ function and lead to severe complications. Treatment focuses on correcting the underlying cause and administering bicarbonate to neutralize excess acids.
What Causes Microvillus inclusion disease?
Microvillus inclusion disease is primarily caused by mutations in the MYO5B gene located on chromosome 18. The MYO5B gene encodes the motor protein myosin Vb, which is crucial for the trafficking of vesicles containing membrane proteins to the apical surface of epithelial cells. Mutations in MYO5B can lead to altered motor function of myosin Vb, impairing its ability to transport cargo effectively. This disruption in protein trafficking results in the accumulation of vesicles within the cytoplasm, forming characteristic microvillus inclusions. The impaired trafficking affects the organization of the apical membrane, leading to dysfunction in nutrient absorption and ion transport. Neighboring cells and tissues experience a loss of epithelial polarity and barrier function, exacerbating nutrient malabsorption. Neuroinflammation may occur as a secondary response to chronic epithelial injury and stress. Although neuroinflammation is not a primary feature, it can contribute to systemic symptoms. White matter degeneration is not directly associated with this disease, but chronic malnutrition can have indirect effects on neurological development. Symptoms such as severe diarrhea and failure to thrive appear due to the direct impact on intestinal epithelial cells. The pattern of symptoms is influenced by the specific mutations and their impact on myosin Vb function. Disease severity varies due to differences in mutation types, residual protein function, and potential compensatory mechanisms. Some patients may have milder forms if partial function of myosin Vb is retained. Genetic background and environmental factors also contribute to the variability in clinical presentation. Understanding these molecular mechanisms opens potential avenues for targeted therapeutic interventions.
How is Microvillus inclusion disease Diagnosed?
Typical age of diagnosis: Microvillus inclusion disease is typically diagnosed in the neonatal period or early infancy, often within the first few weeks of life. Diagnosis usually occurs after the infant presents with severe, intractable diarrhea that does not respond to standard treatments. The condition is suspected based on clinical presentation and family history, especially if there is a known genetic predisposition. Early diagnosis is crucial for managing symptoms and improving outcomes.
Clinicians look for signs of severe, persistent diarrhea and failure to thrive in infants. A detailed family history is important, especially if there are siblings with similar symptoms or known genetic conditions. Physical examination may reveal dehydration and malnutrition due to chronic diarrhea. This step helps to rule out other common causes of diarrhea and directs the clinician towards considering rare genetic disorders.
Abdominal ultrasound is commonly used to assess the gastrointestinal tract. Specific abnormalities such as bowel wall thickening or dilated loops of bowel may be visible. These findings can support the diagnosis but are not definitive on their own. Imaging helps exclude other structural causes of diarrhea, such as intestinal obstructions or malformations.
Stool analysis and blood tests are ordered to assess electrolyte imbalances and nutrient malabsorption. Biomarkers such as low serum albumin and electrolyte disturbances are indicative of malabsorption. Abnormal results guide the clinician towards further genetic testing or biopsy. These tests help differentiate microvillus inclusion disease from other causes of malabsorption.
Genetic testing focuses on sequencing the MYO5B gene, among others. Mutations such as point mutations or deletions in this gene are commonly found. Positive results confirm the diagnosis and can guide prognosis and treatment. Genetic results are crucial for family counseling regarding recurrence risks in future pregnancies.
Microvillus inclusion disease Treatment Options
Antidiarrheal agents are used to manage symptoms by reducing intestinal motility. Loperamide is a specific drug that may be used, although its efficacy is limited in severe cases. Clinical evidence suggests modest improvement in stool output but not in overall nutritional status. Limitations include potential side effects such as constipation and abdominal pain. These agents are often used in conjunction with other supportive measures.
Nutritional rehabilitation focuses on optimizing caloric intake and addressing malnutrition. Techniques include enteral feeding strategies and specialized diets. Sessions are frequent, often daily, and continue until the child achieves stable growth. Measurable outcomes include weight gain and improved nutritional markers. Long-term benefits include enhanced growth and development.
Intestinal transplantation is considered for patients with irreversible intestinal failure. The procedure involves replacing the diseased intestine with a donor organ. Expected benefits include improved nutrient absorption and quality of life. Surgical risks include rejection and infection, necessitating lifelong immunosuppression. Post-operative care requires close monitoring and regular follow-up.
The care team typically includes gastroenterologists, dietitians, and genetic counselors. Interventions focus on nutritional support, hydration, and managing complications. Psychosocial support strategies are crucial for family coping and adaptation. Family education covers disease management and emergency care plans. Long-term monitoring involves regular assessments of growth, development, and nutritional status.
When to See a Doctor for Microvillus inclusion disease
- Severe dehydration — This is an emergency because it can lead to shock and organ failure if not promptly treated.
- Persistent vomiting — This is critical as it can cause electrolyte imbalance and severe dehydration.
- Bloody diarrhea — This is an emergency due to the risk of significant blood loss and potential for severe infection.
- Chronic diarrhea — This is concerning as it may indicate malabsorption and requires medical evaluation.
- Failure to thrive in infants — This is significant as it suggests nutritional deficiencies and needs pediatric assessment.
- Frequent infections — This is concerning as it may indicate compromised immunity and warrants further investigation.
- Mild abdominal discomfort — Monitor for changes in severity or frequency and maintain hydration.
- Occasional loose stools — Keep track of frequency and ensure adequate fluid intake to prevent dehydration.
Microvillus inclusion disease — Frequently Asked Questions
Is this condition hereditary?
Microvillus inclusion disease is typically inherited in an autosomal recessive pattern, meaning both parents must be carriers for a child to be affected. The probability of passing the condition to children is 25% if both parents are carriers. De novo mutations are rare but possible. Carrier status does not usually cause symptoms, but genetic counseling is recommended for family planning. Genetic counseling can help assess risks and discuss testing options.
What is the life expectancy for someone with this condition?
Life expectancy varies greatly depending on the age of onset and the effectiveness of nutritional support. Early diagnosis and intervention can improve outcomes, but complications such as infections and liver disease can worsen prognosis. Mortality is often due to severe dehydration, malnutrition, or complications from parenteral nutrition. Treatment, including parenteral nutrition, can extend survival significantly. Realistic expectations should include ongoing medical management and potential for complications.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis involves a combination of clinical evaluation, genetic testing, and intestinal biopsy. The time from first symptoms to diagnosis can vary, often taking several months due to the rarity of the condition. Pediatric gastroenterologists and geneticists are typically involved in the diagnostic process. Delays in diagnosis are common due to symptom overlap with other gastrointestinal disorders. Confirmation usually comes from genetic testing and histological examination of intestinal tissue.
Are there any new treatments or clinical trials available?
Research is ongoing, with promising studies focusing on gene therapy and cellular-level interventions. Novel approaches such as MYO5B gene correction are being explored. Clinical trials can be found on ClinicalTrials.gov by searching for microvillus inclusion disease. Discussing these options with your doctor can provide insights into eligibility and potential benefits. New treatments may become available in the next few years, but timelines are uncertain.
How does this condition affect daily life and activities?
The condition can significantly impact mobility and self-care, especially in severe cases requiring parenteral nutrition. Educational challenges may arise due to frequent medical appointments and hospitalizations. Social and emotional challenges include isolation and stress for both patients and families. The family burden can be substantial, necessitating support and adaptations. Supportive measures such as nutritional counseling and home care services can greatly assist.
Learn More
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Microvillus inclusion disease: a short review of literature.
Kovilveettil AN · Gastroenterol Hepatol Bed Bench · 2025 · PMID: 40734809
- 2.Uncovering the Relationship Between Genes and Phenotypes Beyond the Gut in Microvillus Inclusion Disease.
Sun M, Pylypenko O, Zhou Z et al. · Cell Mol Gastroenterol Hepatol · 2024 · PMID: 38307491
- 3.UNC45A deficiency causes microvillus inclusion disease-like phenotype by impairing myosin VB-dependent apical trafficking.
Duclaux-Loras R, Lebreton C, Berthelet J et al. · J Clin Invest · 2022 · PMID: 35575086
- 4.Altered MYO5B Function Underlies Microvillus Inclusion Disease: Opportunities for Intervention at a Cellular Level.
Bowman DM, Kaji I, Goldenring JR · Cell Mol Gastroenterol Hepatol · 2022 · PMID: 35660026
- 5.Gastrointestinal microvillus inclusion disease.
Schofield DE, Agostini RM Jr, Yunis EJ · Am J Clin Pathol · 1992 · PMID: 1319670
- 6.Pharmacological and Parenteral Nutrition-Based Interventions in Microvillus Inclusion Disease.
Leng C, Rings EHHM, de Wildt SN et al. · J Clin Med · 2020 · PMID: 33374831
- 7.Pathophysiology in Microvillus inclusion disease.
Reinshagen K, Naim H, Heusipp G et al. · Z Gastroenterol · 2006 · PMID: 16902898
- 8.Microvillus inclusion disease-causing MYO5B point mutations exert differential effects on motor function.
Bowman DM, Meenderink LM, Thomas KS et al. · J Biol Chem · 2025 · PMID: 39978676
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-06-13